Skip to main content

Table 1 Characteristics of patients with AD and controls of cohort 1

From: Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

Diagnosis

Number

M/F

Ages Mean ± SD (range)

MMSE scores Mean ± SD (range)

AD

20

8/12

77.4 ± 7.7 (60–89)

12.8 ± 5.0 (2–19)

Control

15

1/14

76.3 ± 3.2 (71–84)

N/A

  1. M/F Male/female, AD Alzheimer’s disease, MMSE Mini-mental state examination, N/A not available
Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326